ChemicalBook >> CAS DataBase List >>C16 Sphingomyelin-d9 (d18:1/16:0-d9)

C16 Sphingomyelin-d9 (d18:1/16:0-d9)

CAS No.
2415226-88-7
Chemical Name:
C16 Sphingomyelin-d9 (d18:1/16:0-d9)
Synonyms
C16 Sphingomyelin-d9 (d18:1/16:0-d9)
CBNumber:
CB65540877
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
MSDS File:
SDS
Last updated:2025-08-21 14:05:29

C16 Sphingomyelin-d9 (d18:1/16:0-d9) Properties

solubility Ethanol: 10 mg/ml

C16 Sphingomyelin-d9 (d18:1/16:0-d9) price More Price(4)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 27551 C16 Sphingomyelin-d9 (d18:1/16:0-d9) ≥99%deuteratedforms(d1-d9) 2415226-88-7 500μg $160 2026-04-30 Buy
Cayman Chemical 27551 C16 Sphingomyelin-d9 (d18:1/16:0-d9) ≥99%deuteratedforms(d1-d9) 2415226-88-7 1mg $304 2026-04-30 Buy
ChemScene CS-1140848 N-Palmitoyl-D-sphingomyelin-d9 99.9% 2415226-88-7 500??g $379 2026-06-04 Buy
ChemScene CS-1140848 N-Palmitoyl-D-sphingomyelin-d9 99.9% 2415226-88-7 1mg $715 2026-06-04 Buy
Product number Packaging Price Buy
27551 500μg $160 Buy
27551 1mg $304 Buy
CS-1140848 500??g $379 Buy
CS-1140848 1mg $715 Buy

C16 Sphingomyelin-d9 (d18:1/16:0-d9) Chemical Properties, Uses, Production

Uses

N-Palmitoyl-D-sphingomyelin-d9 (Sphingomyelin 16:0-d9) is deuterium labeled N-Palmitoyl-D-sphingomyelin. N-Palmitoyl-D-sphingomyelin (Sphingomyelin 16:0) (Compound SM-03) can be used for the synthesis of lipid nanoparticles[1][2].

References

[1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. DOI:10.1177/1060028018797110
[2] Dandan LING, et al. Lipid compounds and lipid nanoparticle compositions. Patent. WO2023056914.
[3] A. FIEDOROWICZ . Sphingolipid profiles are altered in prefrontal cortex of rats under acute hyperglycemia[J]. Neuroscience, 2014, 256: Pages 282-291. DOI: 10.1016/j.neuroscience.2013.10.022
[4] MARIA PRAGGASTIS. A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele.[J]. Journal of Neuroscience, 2015, 35 21: 8091-8106. DOI: 10.1523/jneurosci.4173-14.2015
[5] HUSSAIN MOHAMAD AWWAD . Choline-phospholipids inter-conversion is altered in elderly patients with prostate cancer[J]. Biochimie, 2016, 126: Pages 108-114. DOI: 10.1016/j.biochi.2016.01.003
[6] RODRIGO F.M. DE ALMEIDA . Lipid Rafts have Different Sizes Depending on Membrane Composition: A Time-resolved Fluorescence Resonance Energy Transfer Study[J]. Journal of Molecular Biology, 2005, 346 4: Pages 1109-1120. DOI: 10.1016/j.jmb.2004.12.026
[7] KATRIN K HALLING. Cholesterol interactions with fluid-phase phospholipids: effect on the lateral organization of the bilayer.[J]. Biophysical journal, 2008, 95 8: 3861-3871. DOI: 10.1529/biophysj.108.133744

C16 Sphingomyelin-d9 (d18:1/16:0-d9) Preparation Products And Raw materials

Raw materials

Preparation Products

C16 Sphingomyelin-d9 (d18:1/16:0-d9) Suppliers

Global Suppliers ( 7)
Supplier Tel Email Country ProdList Advantage
Shanghai Hongye Biotechnology Co. Ltd 400-9205774 400-920-5774 sales@glpbio.cn China 6705 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767 sales@chemegen.com China 11123 58
CHINA ISOTOPE CO., LIMITED 02151600108 13062666369 info@isotopechem.com China 4721 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11963 58
C16 Sphingomyelin-d9 (d18:1/16:0-d9) 2415226-88-7